Corvus Pharmaceuticals, Inc. (CRVS) SEC filings
CRVS SEC filings moved a median of -0.92% by the close. CRVS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CRVS overview →
55 measured CRVS SEC filing events.
Where these CRVS SEC filings landedvs 55 measured CRVS SEC filing reactions
| Middle 50% of CRVS SEC filing reactions | -3.65% to +4.81% |
|---|---|
| Median reaction (to close) | -0.92% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 CRVS SEC filing events with a measured close landed between -3.65% and +4.81%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Corvus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +4.76% | +8.66% | |
| Form 8-K Corvus Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +4.76% | +8.66% | |
| Form 8-K Corvus Pharmaceuticals, For: Jul 21 | SEC filing · Form 8-K | +0.29% | +0.29% | |
| Form 8-K Corvus Pharmaceuticals, For: Jun 11 | SEC filing · Form 8-K | +2.42% | -0.92% | |
| Form 8-K Corvus Pharmaceuticals, For: May 14 | SEC filing · Form 8-K | -5.16% | -13.03% | |
| Form 10-Q Corvus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +2.97% | +5.00% | |
| Form 8-K Corvus Pharmaceuticals, For: May 07 | SEC filing · Form 8-K | +2.97% | +5.00% | |
| Form S-8 Corvus Pharmaceuticals, | SEC filing · Form S-8 | +2.97% | +5.00% | |
| Form DEF 14A Corvus Pharmaceuticals, For: Jun 11 | SEC filing · Form DEF | +2.39% | -0.99% | |
| Form DEFA14A Corvus Pharmaceuticals, | SEC filing · Form DEFA14A | +2.39% | -0.99% | |
| Form 8-K Corvus Pharmaceuticals, For: Apr 22 | SEC filing · Form 8-K | -0.34% | +0.44% | |
| Form 8-K Corvus Pharmaceuticals, For: Mar 13 | SEC filing · Form 8-K | +2.73% | -1.42% | |
| Form S-3ASR Corvus Pharmaceuticals, | SEC filing · Form S-3ASR | +2.73% | -1.42% | |
| Form 10-K Corvus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +2.73% | -1.42% | |
| Form 8-K Corvus Pharmaceuticals, For: Mar 12 | SEC filing · Form 8-K | +2.73% | -1.42% | |
| Form 8-K Corvus Pharmaceuticals, For: Jan 21 | SEC filing · Form 8-K | +0.70% | -1.80% | |
| Form S-3MEF Corvus Pharmaceuticals, | SEC filing · Form S-3MEF | +5.60% | +5.02% | |
| Form 8-K Corvus Pharmaceuticals, For: Jan 20 | SEC filing · Form 8-K | +2.67% | +58.48% | |
| Form 10-Q Corvus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.91% | -0.13% | |
| Form 8-K Corvus Pharmaceuticals, For: Nov 04 | SEC filing · Form 8-K | +3.91% | -0.13% | |
| Form 8-K Corvus Pharmaceuticals, For: Oct 02 | SEC filing · Form 8-K | +1.56% | +2.13% | |
| Form 10-Q Corvus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -1.19% | +2.86% | |
| Form 8-K Corvus Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -1.19% | +2.86% | |
| Form 8-K Corvus Pharmaceuticals, For: Jun 12 | SEC filing · Form 8-K | -0.94% | +0.23% | |
| Form 8-K Corvus Pharmaceuticals, For: Jun 04 | SEC filing · Form 8-K | +3.00% | -6.25% | |
| Form 10-Q Corvus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -0.00% | +5.98% | |
| Form 8-K Corvus Pharmaceuticals, For: May 08 | SEC filing · Form 8-K | -0.00% | +5.98% | |
| Form S-8 Corvus Pharmaceuticals, | SEC filing · Form S-8 | -0.00% | +5.98% | |
| Form DEF 14A Corvus Pharmaceuticals, For: Jun 12 | SEC filing · Form DEF | +0.66% | -5.41% | |
| Form DEFA14A Corvus Pharmaceuticals, | SEC filing · Form DEFA14A | +0.66% | -5.41% | |
| Form 8-K Corvus Pharmaceuticals, For: Apr 08 | SEC filing · Form 8-K | -0.33% | -4.33% | |
| Form 10-K Corvus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +4.50% | -16.25% | |
| Form 8-K Corvus Pharmaceuticals, For: Mar 25 | SEC filing · Form 8-K | +4.50% | -16.25% | |
| Form 8-K Corvus Pharmaceuticals, For: Jan 13 | SEC filing · Form 8-K | -0.47% | -2.07% | |
| Form 8-K Corvus Pharmaceuticals, For: Dec 18 | SEC filing · Form 8-K | -1.00% | -6.00% | |
| Form 10-Q Corvus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -1.21% | -10.94% | |
| Form 8-K Corvus Pharmaceuticals, For: Nov 12 | SEC filing · Form 8-K | -1.21% | -10.94% | |
| Form 8-K Corvus Pharmaceuticals, For: Oct 22 | SEC filing · Form 8-K | +0.07% | +0.52% | |
| Form EFFECT Corvus Pharmaceuticals, | SEC filing · Form EFFECT | -0.05% | +10.21% | |
| Form 10-Q Corvus Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +0.78% | +2.81% | |
| Form 8-K Corvus Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +0.78% | +2.81% | |
| Form S-3 Corvus Pharmaceuticals, | SEC filing · Form S-3 | +0.78% | +2.81% | |
| Form 8-K Corvus Pharmaceuticals, For: Jun 13 | SEC filing · Form 8-K | -3.71% | -5.39% | |
| Form 10-Q Corvus Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.34% | +4.81% | |
| Form S-8 Corvus Pharmaceuticals, | SEC filing · Form S-8 | -1.34% | +4.81% | |
| Form 8-K Corvus Pharmaceuticals, For: May 01 | SEC filing · Form 8-K | +2.76% | -7.18% | |
| Form 8-K Corvus Pharmaceuticals, For: May 06 | SEC filing · Form 8-K | +2.76% | -7.18% | |
| Form 8-K Corvus Pharmaceuticals, For: May 01 | SEC filing · Form 8-K | -1.71% | -1.71% | |
| Form DEF 14A Corvus Pharmaceuticals, For: Jun 13 | SEC filing · Form DEF | +0.00% | +6.76% | |
| Form DEFA14A Corvus Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +6.76% | |
| Form 10-K Corvus Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +1.56% | -3.65% | |
| Form 8-K Corvus Pharmaceuticals, For: Mar 19 | SEC filing · Form 8-K | +1.56% | -3.65% | |
| Form 8-K Corvus Pharmaceuticals, For: Jan 23 | SEC filing · Form 8-K | +0.00% | -3.33% | |
| Form 10-Q Corvus Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -4.24% | -3.03% | |
| Form 8-K Corvus Pharmaceuticals, For: Nov 07 | SEC filing · Form 8-K | -4.24% | -3.03% |
Keep exploring
More CRVS: earnings → · analyst actions → · CRVS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Amarin Corporation plc - American Depositary Shares (AMRN) | 211 | +0.30% | 55% |
| BioRestorative Therapies, Inc. (BRTX) | 209 | -0.82% | 38% |
| Journey Medical Corporation (DERM) | 208 | 0.00% | 50% |
| Windtree Therapeutics, Inc. (WINT) | 207 | -1.40% | 27% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.